 Kristine Kuhn
Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spondylarthritis | 10 | 2022 | 36 | 4.800 |
Why?
| | Spondylitis, Ankylosing | 6 | 2022 | 43 | 3.100 |
Why?
| | Gastrointestinal Microbiome | 12 | 2023 | 501 | 2.960 |
Why?
| | Microbiota | 9 | 2023 | 647 | 2.320 |
Why?
| | Arthritis, Rheumatoid | 13 | 2023 | 1003 | 2.210 |
Why?
| | Arthritis, Experimental | 6 | 2023 | 130 | 1.990 |
Why?
| | Intestines | 5 | 2021 | 326 | 1.750 |
Why?
| | Interleukin-17 | 3 | 2023 | 104 | 1.670 |
Why?
| | Inflammatory Bowel Diseases | 8 | 2023 | 284 | 1.630 |
Why?
| | Arthritis | 4 | 2022 | 109 | 1.530 |
Why?
| | Crohn Disease | 3 | 2023 | 196 | 1.420 |
Why?
| | Intestinal Mucosa | 6 | 2023 | 532 | 1.340 |
Why?
| | Intraepithelial Lymphocytes | 2 | 2018 | 12 | 1.190 |
Why?
| | Inflammation | 10 | 2023 | 2478 | 1.130 |
Why?
| | Immunity, Mucosal | 5 | 2020 | 84 | 1.080 |
Why?
| | Rheumatology | 2 | 2023 | 88 | 0.960 |
Why?
| | Tryptophan | 2 | 2023 | 136 | 0.890 |
Why?
| | Dysbiosis | 4 | 2022 | 146 | 0.890 |
Why?
| | Th17 Cells | 1 | 2024 | 58 | 0.880 |
Why?
| | Autoantibodies | 5 | 2022 | 1346 | 0.840 |
Why?
| | Interleukin-6 | 2 | 2017 | 676 | 0.800 |
Why?
| | T-Lymphocytes | 3 | 2021 | 1737 | 0.800 |
Why?
| | Immunoglobulin A | 1 | 2022 | 166 | 0.760 |
Why?
| | Mentoring | 1 | 2022 | 100 | 0.720 |
Why?
| | Metagenomics | 1 | 2021 | 131 | 0.680 |
Why?
| | Metabolomics | 2 | 2022 | 521 | 0.670 |
Why?
| | Colon | 3 | 2022 | 233 | 0.650 |
Why?
| | Bacteroidaceae | 1 | 2017 | 3 | 0.580 |
Why?
| | Osteoarthritis | 1 | 2020 | 171 | 0.580 |
Why?
| | Citrobacter rodentium | 1 | 2017 | 6 | 0.580 |
Why?
| | Enterobacteriaceae Infections | 1 | 2017 | 32 | 0.570 |
Why?
| | Biomedical Research | 1 | 2022 | 585 | 0.550 |
Why?
| | Mice | 19 | 2024 | 14863 | 0.550 |
Why?
| | Skin | 2 | 2020 | 655 | 0.520 |
Why?
| | Autoimmune Diseases | 3 | 2019 | 382 | 0.510 |
Why?
| | Gastrointestinal Tract | 1 | 2018 | 169 | 0.510 |
Why?
| | Animals | 22 | 2024 | 31698 | 0.480 |
Why?
| | Collagen Type II | 2 | 2018 | 48 | 0.450 |
Why?
| | Collagen | 4 | 2023 | 415 | 0.450 |
Why?
| | Cytokines | 6 | 2022 | 1840 | 0.380 |
Why?
| | Humans | 38 | 2023 | 114662 | 0.380 |
Why?
| | Bacteria | 2 | 2015 | 725 | 0.370 |
Why?
| | Antigens | 2 | 2013 | 318 | 0.360 |
Why?
| | Receptors, Complement 3d | 2 | 2008 | 130 | 0.350 |
Why?
| | Immunity, Innate | 3 | 2020 | 720 | 0.330 |
Why?
| | Antibodies, Monoclonal | 2 | 2022 | 1262 | 0.300 |
Why?
| | Receptors, Complement 3b | 1 | 2008 | 81 | 0.300 |
Why?
| | Cell Proliferation | 1 | 2014 | 2186 | 0.290 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2019 | 485 | 0.290 |
Why?
| | Disease Models, Animal | 7 | 2022 | 3532 | 0.250 |
Why?
| | Germ-Free Life | 3 | 2021 | 28 | 0.250 |
Why?
| | Symbiosis | 2 | 2017 | 64 | 0.240 |
Why?
| | Hypoxia-Inducible Factor 1 | 2 | 2015 | 68 | 0.240 |
Why?
| | Feces | 3 | 2022 | 373 | 0.230 |
Why?
| | Peptides, Cyclic | 1 | 2006 | 253 | 0.230 |
Why?
| | Ileitis | 1 | 2023 | 26 | 0.220 |
Why?
| | Biomarkers | 3 | 2022 | 3408 | 0.210 |
Why?
| | Case-Control Studies | 2 | 2021 | 3003 | 0.210 |
Why?
| | Bifidobacterium longum | 1 | 2022 | 5 | 0.210 |
Why?
| | Autoantigens | 2 | 2022 | 396 | 0.210 |
Why?
| | Oryza | 1 | 2022 | 20 | 0.200 |
Why?
| | Colitis | 2 | 2015 | 223 | 0.200 |
Why?
| | Erythema Nodosum | 1 | 2022 | 3 | 0.200 |
Why?
| | Pyoderma Gangrenosum | 1 | 2022 | 5 | 0.200 |
Why?
| | Disease Susceptibility | 2 | 2021 | 316 | 0.200 |
Why?
| | Anti-Citrullinated Protein Antibodies | 2 | 2021 | 90 | 0.190 |
Why?
| | Antirheumatic Agents | 1 | 2023 | 255 | 0.190 |
Why?
| | Granzymes | 1 | 2021 | 40 | 0.190 |
Why?
| | Mentors | 1 | 2022 | 156 | 0.180 |
Why?
| | Uveitis | 1 | 2022 | 115 | 0.180 |
Why?
| | Cell Differentiation | 2 | 2024 | 1700 | 0.180 |
Why?
| | Metabolic Networks and Pathways | 1 | 2021 | 168 | 0.170 |
Why?
| | Bacteriophages | 1 | 2021 | 75 | 0.170 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 167 | 0.170 |
Why?
| | Bacteroides | 2 | 2019 | 16 | 0.170 |
Why?
| | Glucose Intolerance | 1 | 2021 | 136 | 0.160 |
Why?
| | Epithelial Cells | 2 | 2015 | 950 | 0.160 |
Why?
| | Fatty Acids, Volatile | 2 | 2018 | 47 | 0.160 |
Why?
| | Homeodomain Proteins | 1 | 2022 | 463 | 0.160 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2021 | 285 | 0.160 |
Why?
| | Adaptive Immunity | 1 | 2020 | 155 | 0.160 |
Why?
| | Disease | 1 | 2019 | 85 | 0.160 |
Why?
| | Immunoglobulin G | 1 | 2022 | 770 | 0.160 |
Why?
| | Mice, Transgenic | 2 | 2022 | 1947 | 0.160 |
Why?
| | Lymphocytes | 1 | 2020 | 330 | 0.150 |
Why?
| | Immune System | 1 | 2019 | 172 | 0.150 |
Why?
| | Vascular Diseases | 1 | 2021 | 230 | 0.150 |
Why?
| | Immune Tolerance | 1 | 2020 | 323 | 0.150 |
Why?
| | Monocytes | 1 | 2020 | 502 | 0.150 |
Why?
| | Mucous Membrane | 1 | 2018 | 108 | 0.150 |
Why?
| | Homosexuality, Male | 1 | 2019 | 170 | 0.150 |
Why?
| | HIV | 1 | 2019 | 208 | 0.150 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 427 | 0.140 |
Why?
| | Pilot Projects | 1 | 2022 | 1373 | 0.140 |
Why?
| | Obesity | 2 | 2021 | 2508 | 0.140 |
Why?
| | Cell Membrane Permeability | 1 | 2017 | 83 | 0.140 |
Why?
| | Computational Biology | 1 | 2021 | 530 | 0.140 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2017 | 90 | 0.140 |
Why?
| | Mice, Inbred C57BL | 5 | 2022 | 4692 | 0.140 |
Why?
| | Antibody Formation | 2 | 2008 | 266 | 0.130 |
Why?
| | Histones | 1 | 2020 | 535 | 0.130 |
Why?
| | Sulfatases | 1 | 2015 | 1 | 0.130 |
Why?
| | Software | 1 | 2019 | 530 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 245 | 0.120 |
Why?
| | Secretory Vesicles | 1 | 2015 | 24 | 0.120 |
Why?
| | Claudin-1 | 1 | 2015 | 21 | 0.120 |
Why?
| | Antigens, Bacterial | 1 | 2015 | 112 | 0.120 |
Why?
| | Tight Junctions | 1 | 2015 | 68 | 0.120 |
Why?
| | Pandemics | 1 | 2022 | 1317 | 0.120 |
Why?
| | Molecular Mimicry | 1 | 2014 | 35 | 0.120 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1518 | 0.120 |
Why?
| | Autoimmunity | 3 | 2020 | 813 | 0.120 |
Why?
| | Genome-Wide Association Study | 1 | 2020 | 1177 | 0.110 |
Why?
| | Homeostasis | 1 | 2017 | 573 | 0.110 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1342 | 0.110 |
Why?
| | Physicians | 1 | 2021 | 772 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1481 | 0.110 |
Why?
| | Rheumatologists | 2 | 2023 | 12 | 0.110 |
Why?
| | Wound Healing | 1 | 2014 | 258 | 0.100 |
Why?
| | Male | 13 | 2022 | 55583 | 0.100 |
Why?
| | Host-Pathogen Interactions | 1 | 2015 | 295 | 0.100 |
Why?
| | Female | 12 | 2022 | 59493 | 0.090 |
Why?
| | Mice, Inbred DBA | 3 | 2007 | 173 | 0.090 |
Why?
| | Adult | 8 | 2021 | 30544 | 0.090 |
Why?
| | Mice, Knockout | 1 | 2017 | 2568 | 0.090 |
Why?
| | Biopsy | 1 | 2014 | 1036 | 0.090 |
Why?
| | Middle Aged | 7 | 2021 | 26733 | 0.090 |
Why?
| | Carcinogenesis | 2 | 2022 | 177 | 0.090 |
Why?
| | Citrulline | 2 | 2008 | 40 | 0.090 |
Why?
| | United States | 2 | 2022 | 12181 | 0.080 |
Why?
| | Rheumatoid Factor | 2 | 2008 | 157 | 0.080 |
Why?
| | Porphyromonas gingivalis | 1 | 2008 | 17 | 0.080 |
Why?
| | Periodontitis | 1 | 2008 | 42 | 0.080 |
Why?
| | Freund's Adjuvant | 1 | 2008 | 17 | 0.080 |
Why?
| | HIV Infections | 2 | 2019 | 2469 | 0.080 |
Why?
| | Antibodies, Bacterial | 1 | 2008 | 119 | 0.070 |
Why?
| | Joints | 1 | 2008 | 84 | 0.070 |
Why?
| | Complement C3 | 1 | 2008 | 188 | 0.070 |
Why?
| | Immunoglobulin Isotypes | 1 | 2006 | 32 | 0.070 |
Why?
| | Lupus Vulgaris | 1 | 2006 | 4 | 0.070 |
Why?
| | Antigen-Antibody Reactions | 1 | 2006 | 50 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2319 | 0.060 |
Why?
| | Cohort Studies | 3 | 2021 | 4895 | 0.060 |
Why?
| | Antibody Specificity | 1 | 2006 | 176 | 0.060 |
Why?
| | Apoptosis | 1 | 2014 | 2362 | 0.060 |
Why?
| | Synovial Membrane | 1 | 2006 | 75 | 0.060 |
Why?
| | Immunization | 1 | 2008 | 397 | 0.060 |
Why?
| | Fibrinogen | 1 | 2006 | 154 | 0.060 |
Why?
| | Paneth Cells | 1 | 2023 | 17 | 0.060 |
Why?
| | Risk Factors | 3 | 2023 | 8632 | 0.060 |
Why?
| | Cattle | 1 | 2006 | 920 | 0.050 |
Why?
| | Butyrates | 1 | 2023 | 53 | 0.050 |
Why?
| | Azoxymethane | 1 | 2022 | 16 | 0.050 |
Why?
| | Dextran Sulfate | 1 | 2022 | 70 | 0.050 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2022 | 8 | 0.050 |
Why?
| | Lactobacillus | 1 | 2022 | 24 | 0.050 |
Why?
| | B-Lymphocytes | 1 | 2007 | 766 | 0.050 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 39 | 0.050 |
Why?
| | Delayed Diagnosis | 1 | 2021 | 70 | 0.050 |
Why?
| | HLA-B27 Antigen | 1 | 2021 | 11 | 0.050 |
Why?
| | Citrullination | 1 | 2020 | 12 | 0.050 |
Why?
| | Interleukin-2 | 1 | 2001 | 413 | 0.040 |
Why?
| | Aged | 4 | 2021 | 19069 | 0.040 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2022 | 308 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2021 | 197 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 1 | 2020 | 397 | 0.040 |
Why?
| | Immunophenotyping | 1 | 2020 | 274 | 0.040 |
Why?
| | Consensus | 1 | 2022 | 537 | 0.040 |
Why?
| | Killer Cells, Natural | 1 | 2001 | 380 | 0.040 |
Why?
| | Buspirone | 1 | 1998 | 4 | 0.040 |
Why?
| | Diet, Western | 1 | 2018 | 66 | 0.040 |
Why?
| | Mitochondria | 1 | 2023 | 747 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2001 | 719 | 0.040 |
Why?
| | Serotonin Receptor Agonists | 1 | 1998 | 27 | 0.040 |
Why?
| | Lorazepam | 1 | 1998 | 23 | 0.040 |
Why?
| | Anti-Anxiety Agents | 1 | 1998 | 42 | 0.040 |
Why?
| | Organ Specificity | 1 | 2018 | 268 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2020 | 477 | 0.040 |
Why?
| | DNA, Bacterial | 1 | 2019 | 311 | 0.040 |
Why?
| | Time Factors | 2 | 2006 | 6114 | 0.040 |
Why?
| | Phylogeny | 1 | 2021 | 789 | 0.040 |
Why?
| | Bile Acids and Salts | 1 | 2018 | 171 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2018 | 217 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2019 | 1016 | 0.040 |
Why?
| | Qualitative Research | 1 | 2021 | 934 | 0.030 |
Why?
| | Procollagen | 1 | 1976 | 19 | 0.030 |
Why?
| | Diet | 1 | 2022 | 1080 | 0.030 |
Why?
| | Anxiety Disorders | 1 | 1998 | 303 | 0.030 |
Why?
| | Sexual Behavior | 1 | 2019 | 440 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 128 | 0.030 |
Why?
| | Genes, Bacterial | 1 | 2015 | 157 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2015 | 345 | 0.030 |
Why?
| | Adiposity | 1 | 2018 | 457 | 0.030 |
Why?
| | Gene Deletion | 1 | 2015 | 356 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2022 | 4411 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 2015 | 337 | 0.030 |
Why?
| | Cell Line | 2 | 2015 | 2636 | 0.030 |
Why?
| | Mothers | 1 | 2018 | 651 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2015 | 588 | 0.030 |
Why?
| | Fibroblasts | 1 | 1976 | 838 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 4408 | 0.020 |
Why?
| | Quality of Life | 1 | 2021 | 2353 | 0.020 |
Why?
| | Liver | 1 | 2018 | 1637 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2015 | 1131 | 0.020 |
Why?
| | Young Adult | 2 | 2019 | 10466 | 0.020 |
Why?
| | Signal Transduction | 2 | 2015 | 4512 | 0.020 |
Why?
| | Immunoglobulins | 1 | 2008 | 142 | 0.020 |
Why?
| | Pregnancy | 1 | 2018 | 5518 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2008 | 362 | 0.020 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2007 | 107 | 0.020 |
Why?
| | Infant | 1 | 2018 | 7961 | 0.020 |
Why?
| | Reference Values | 1 | 2006 | 743 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2007 | 1037 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2006 | 1692 | 0.010 |
Why?
| | Mice, Inbred CBA | 1 | 2001 | 49 | 0.010 |
Why?
| | Peptides | 1 | 2006 | 848 | 0.010 |
Why?
| | Interleukin-12 | 1 | 2001 | 110 | 0.010 |
Why?
| | Adolescent | 1 | 2019 | 17841 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2001 | 1230 | 0.010 |
Why?
| | Manifest Anxiety Scale | 1 | 1998 | 3 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2001 | 1842 | 0.010 |
Why?
| | Ehlers-Danlos Syndrome | 1 | 1976 | 14 | 0.010 |
Why?
| | Ascorbic Acid | 1 | 1976 | 110 | 0.010 |
Why?
| | Double-Blind Method | 1 | 1998 | 1660 | 0.010 |
Why?
| | Treatment Outcome | 1 | 1998 | 9088 | 0.000 |
Why?
|
|
Kuhn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|